Jonathan Murphy Buys 663 Shares of Assura Plc (LON:AGR) Stock

Key Points

• Jonathan Murphy, an insider at Assura Plc, purchased 663 shares of the company at GBX 49 ($0.65) each on August 5th, totaling approximately £324.87 ($431.95).
• Assura Plc operates over 600 healthcare properties across the UK and Ireland, serving over six million patients.
• The company has achieved B Corp certification as of July 2024, making it the first FTSE 250 business to receive this certification.

Assura Plc (LON:AGR - Get Free Report) insider Jonathan Murphy bought 663 shares of the stock in a transaction that occurred on Tuesday, August 5th. The shares were purchased at an average cost of GBX 49 ($0.65) per share, for a total transaction of £324.87 ($431.95).

Jonathan Murphy also recently made the following trade(s):

• On Wednesday, July 9th, Jonathan Murphy bought 607 shares of Assura stock. The shares were purchased at an average cost of GBX 50 ($0.66) per share, for a total transaction of £303.50 ($403.54).

Assura Price Performance

LON:AGR traded down GBX 0.12 ($0.00) during mid-day trading on Wednesday, reaching GBX 49.10 ($0.65). 36,925,203 shares of the stock were exchanged, compared to its average volume of 28,466,516. The business has a fifty day moving average price of GBX 49.88 and a 200 day moving average price of GBX 46.43. The firm has a market capitalization of £1.60 billion, a PE ratio of -46.93, a PEG ratio of 3.60 and a beta of 0.37. Assura Plc has a 1-year low of GBX 35.24 ($0.47) and a 1-year high of GBX 50.95 ($0.68). The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.05.

Assura (LON:AGR - Get Free Report) last issued its quarterly earnings results on Monday, July 21st. The real estate investment trust reported GBX 3.50 ($0.05) earnings per share for the quarter. Assura had a negative return on equity of 1.92% and a negative net margin of 18.09%. Research analysts expect that Assura Plc will post 3.5830389 earnings per share for the current fiscal year.

Assura Company Profile

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served. We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G). Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.